Recent advances in the treatment of oligodendrogliomas.

Current Neurology and Neuroscience Reports
Mark Agulnik, Warren P Mason

Abstract

The optimal treatment for patients with oligodendrogliomas is unknown, and current management strategies remain controversial. This past year, further exploration of the molecular genetics of the tumors and its prognostic implications for outcome, evaluation of the utility of positron emission tomography imaging, and the role of radiation and chemotherapy in the treatment of oligodendrogliomas have been reported. It is becoming increasingly apparent that oligodendrogliomas are several distinct diseases on a molecular level, and that key genetic derangements can signify a response to treatment and favorable outcome. The added contributions of recent publications consolidates these emerging impressions. Ultimately, the combination of improved imaging techniques, molecular profiling, and new therapies should result in improved outcome with reduced treatment-related toxicity for patients with newly diagnosed, progressive, and recurrent oligodendrogliomas.

References

May 1, 1990·Annals of Neurology·D R MacdonaldJ G Cairncross
Oct 1, 1984·Journal of Neurosurgery·E R LawsH Okazaki
Oct 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G CairncrossC Schold
Jan 1, 1996·Neurology·W P MasonL M DeAngelis
Sep 1, 1996·Journal of Neurology, Neurosurgery, and Psychiatry·M ScerratiG F Rossi
Apr 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C LeightonG Cairncross
Nov 5, 1998·Neurosurgery·R SoffiettiD Schiffer
Feb 2, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J S SmithR B Jenkins
Apr 6, 2000·Neurology·J D OlsonL M DeAngelis
Dec 6, 2001·European Journal of Nuclear Medicine·A Del SoleG Lucignani
Apr 17, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Francesco PignattiUNKNOWN European Organization for Research and Treatment of Cancer Radiotherapy Cooperative Group
Jan 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jan C BucknerRobert Jenkins
Feb 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer A QuinnHenry S Friedman
May 21, 2003·Seminars in Nuclear Medicine·François BénardRoland Hustinx
Jun 28, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J van den BentUNKNOWN European Organization for Research and Treatment of Cancer Brain Tumor Group
Nov 25, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M BradaC Westbury
Nov 25, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A PaceC M Carapella
May 18, 2004·Journal of Neurology, Neurosurgery, and Psychiatry·V P Collins
May 26, 2004·Neurology·C LebrunUNKNOWN Nice Brain Tumor Study Group
Jul 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K Hoang-XuanJ Y Delattre
Aug 17, 2004·European Journal of Nuclear Medicine and Molecular Imaging·Koen Van LaereLuc Mortelmans
Sep 30, 2004·International Journal of Cancer. Journal International Du Cancer·Maria MöllemannGuido Reifenberger
Jan 1, 2005·Current Opinion in Oncology·Marc SansonKhê Hoang-Xuan
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Mar 11, 2005·The New England Journal of Medicine·Monika E HegiRoger Stupp
Jun 2, 2005·Annals of Neurology·Carol WalkerPeter C Warnke
Jun 7, 2005·International Journal of Radiation Oncology, Biology, Physics·Stephanie E CombsJuergen Debus
Jul 29, 2005·Annals of Neurology·Michèle KujasJean-Yves Delattre

❮ Previous
Next ❯

Citations

Sep 24, 2013·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·J R EllenbogenC Mallucci

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Carol WalkerPeter C Warnke
Hematology/oncology Clinics of North America
Mark Agulnik, Warren P Mason
Current Treatment Options in Neurology
Warren P Mason
© 2022 Meta ULC. All rights reserved